CoChat

The GLP-1 receptor agonists exenatide and liraglutide activate Glucose transport by an AMPK-dependent mechanism

Open access

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Abstract

AIMS/HYPOTHESIS: Potentiation of glucose-induced insulin secretion is the main mechanism of exenatide (EXE) antidiabetic action, however, increased glucose utilization by peripheral tissues has been also reported. We here studied the effect of EXE on glucose uptake by skeletal muscle cells. METHODS: 2-deoxy-glucose (2DG) uptake and intracellular signal pathways were measured in rat L6 skeletal muscle myotubes exposed to 100 nmol/l EXE for up to 48 h. Mechanisms of EXE action were explored by inhibiting AMPK activity with compound C (CC, 40 μmol/l) or siRNAs (2 μmol/l). RESULTS: Time course experiments show that EXE increases glucose uptake up to 48 h achieving its maximal effect, similar to that induced by insulin, after 20 min (2- vs 2.5-fold-increase, respectively). Differently from insulin, EXE does not stimulate: (i) IR β-subunit- and IRS1 tyrosine phosphorylation and binding to p85 regulatory subunit of PI-3kinase; (ii) AKT activation; and (iii) ERK1/2 and JNK1/2 phosphorylation. Conversely, EXE increases phosphorylation of α-subunit of AMPK at Thr172 by 2.5-fold (p < 0.01). Co-incubation of EXE and insulin does not induce additive effects on 2DG-uptake. Inhibition of AMPK with CC, and reduction of AMPK protein expression by siRNA, completely abolish EXE-induced 2DG-uptake. Liraglutide, another GLP-1 receptor agonist, also stimulates AMPK phosphorylation and 2DG-uptake. Moreover, EXE stimulates 2DG-uptake also by L6 myotubes rendered insulin-resistant with methylglyoxal. Finally, EXE also induces glucose transporter Glut-4 translocation to the plasma membrane. CONCLUSIONS/INTERPRETATION: In L6 myotubes, EXE and liraglutide increase glucose uptake in an insulin-independent manner by activating AMPK.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12967-016-0985-7

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 GLP-1R expression in different species and tissues: a Murine endocrine islet cells (αTC1 and βTC3), rat L6 myoblast (Bl) and myotube (Tb), human skeletal muscle (M) and baboon adipose (A) muscle (M) liver (L) and brain (B). Time course of EXE-induced 2DG uptake in L6 myotubes b Myotubes were stimulated with 100 nmol/l for 20 min, and 2, 4, 24, and 48 h and with 100 nmol/l insulin (INS) for 30 min as control. Effects of co-incubation with EXE and insulin on 2DG-glucose uptake c Myotubes were stimulated with either 100 nmol/l EXE, 100 nmo/l INS and both. Data are shown as mean ± SD of three independent experiments. (*p < 0.001, **p < 0.01 vs control)
Fig. 1 GLP-1R expression in different species and tissues: a Murine endocrine islet cells (αTC1 and βTC3), rat L6 myoblast (Bl) and myotube (Tb), human skeletal muscle (M) and baboon adipose (A) muscle (M) liver (L) and brain (B). Time course of EXE-induced 2DG uptake in L6 myotubes b Myotubes were stimulated with 100 nmol/l for 20 min, and 2, 4, 24, and 48 h and with 100 nmol/l insulin (INS) for 30 min as control. Effects of co-incubation with EXE and insulin on 2DG-glucose uptake c Myotubes were stimulated with either 100 nmol/l EXE, 100 nmo/l INS and both. Data are shown as mean ± SD of three independent experiments. (*p < 0.001, **p < 0.01 vs control)CC BY · PubMed Central
Fig. 2 IRβ/IRS1/p85 signaling pathway in L6 myotubes. Cells were stimulated with either 100 nmol/l EXE, 100 nmol/l INS and both. The cells were then lysed and equal amounts of total proteins were immunoprecipitated with anti-IRS-1 antibody and immunoblotted with antiphosphotyrosine antibody (a, b) and anti-p85 subunit of PI 3-kinase (c). To normalize for protein levels the blots were stripped and re-probed with anti-IRS-1 antibody (A and C, top panel). Data are shown as mean ± SD of three independent experiments. (*p < 0.01 vs control)
Fig. 2 IRβ/IRS1/p85 signaling pathway in L6 myotubes. Cells were stimulated with either 100 nmol/l EXE, 100 nmol/l INS and both. The cells were then lysed and equal amounts of total proteins were immunoprecipitated with anti-IRS-1 antibody and immunoblotted with antiphosphotyrosine antibody (a, b) and anti-p85 subunit of PI 3-kinase (c). To normalize for protein levels the blots were stripped and re-probed with anti-IRS-1 antibody (A and C, top panel). Data are shown as mean ± SD of three independent experiments. (*p < 0.01 vs control)CC BY · PubMed Central
Fig. 3 AMPKα activation in L6 myotubes. Cells were stimulated with either 100 nmol/l EXE, 100 nmol/l INS and both. After stimulation, whole lysates were immunoblotted with the phospho-specific antibodies: p-Akt S473 (a), p-GSK3β S21/9 (b), p-ERK1/2 T202/Y204 (c) and p-AMPK T172 (d). In order to normalize for protein levels, blots were stripped and re-probed with anti-AKT, anti ERK1/2, anti-GSK3β and anti-AMPK antibodies. Data are shown as mean ± SD of three independent experiments. (*p < 0.001 vs basal)
Fig. 3 AMPKα activation in L6 myotubes. Cells were stimulated with either 100 nmol/l EXE, 100 nmol/l INS and both. After stimulation, whole lysates were immunoblotted with the phospho-specific antibodies: p-Akt S473 (a), p-GSK3β S21/9 (b), p-ERK1/2 T202/Y204 (c) and p-AMPK T172 (d). In order to normalize for protein levels, blots were stripped and re-probed with anti-AKT, anti ERK1/2, anti-GSK3β and anti-AMPK antibodies. Data are shown as mean ± SD of three independent experiments. (*p < 0.001 vs basal)CC BY · PubMed Central
Fig. 4 Time-course and dose–response experiments of EXE effects on AMPK and ACC phosphorylation in L6 cells. Phosphorylated and total (a, b, c, upper panels) ACC S78/80 (a) and AMPKa T172 (b) protein levels were measured in cells exposed to EXE for increasing time periods. For the dose response curve (c) cells were incubated for 20 min with 0, 1, 10 and 100 nmol/l EXE. Thr172 phosphorylation and total levels of AMPK were shown. Each bar represents the mean ± SD of three independent experiments. (*P < 0.01 and **P < 0.02 vs. control)
Fig. 4 Time-course and dose–response experiments of EXE effects on AMPK and ACC phosphorylation in L6 cells. Phosphorylated and total (a, b, c, upper panels) ACC S78/80 (a) and AMPKa T172 (b) protein levels were measured in cells exposed to EXE for increasing time periods. For the dose response curve (c) cells were incubated for 20 min with 0, 1, 10 and 100 nmol/l EXE. Thr172 phosphorylation and total levels of AMPK were shown. Each bar represents the mean ± SD of three independent experiments. (*P < 0.01 and **P < 0.02 vs. control)CC BY · PubMed Central
Fig. 5 Effects of EXE (20 min or 48 h) and exendin 9–39 on AS-160, TBCD1D and AMPK in differentiated L6 cells. L6 myotubes were stimulated for 20 min with 100 nmol/l EXE, 100 nmol/l exendin 9–39 or the combination of both. Where indicated cells were stimulated with 100 nmol/l INS for 30 min and 100 nmol/l EXE for 20 min or 48 h. The blots were probed with phospho-specific AS160 T642 (a), TBCD1 (b) and AMPKα T172 (c). To normalize for protein levels, the blots were stripped and re-probed with β-actin antibodies. Each bar represents the mean ± SD of three independent experiments. (*p < 0.001 and **p < 0.01 vs. control; #p < 0.02 vs. EXE)
Fig. 5 Effects of EXE (20 min or 48 h) and exendin 9–39 on AS-160, TBCD1D and AMPK in differentiated L6 cells. L6 myotubes were stimulated for 20 min with 100 nmol/l EXE, 100 nmol/l exendin 9–39 or the combination of both. Where indicated cells were stimulated with 100 nmol/l INS for 30 min and 100 nmol/l EXE for 20 min or 48 h. The blots were probed with phospho-specific AS160 T642 (a), TBCD1 (b) and AMPKα T172 (c). To normalize for protein levels, the blots were stripped and re-probed with β-actin antibodies. Each bar represents the mean ± SD of three independent experiments. (*p < 0.001 and **p < 0.01 vs. control; #p < 0.02 vs. EXE)CC BY · PubMed Central
Fig. 6 EXE induces 2DG-uptake via AMPKα activation in L6 myotubes. L6 myotubes were transfected with specific AMPK siRNAs. After transfection, the cells were stimulated with 100 nmol/l EXE or 100 nmol/l INS. Proteins were then extracted and probed with AMPKα (a) and phospho-specific AMPKα T172 (b) antibodies. To normalize the blots for protein levels, the blots were stripped and re-probed with anti-tubulin (a, lower panel) and AMPKα antibodies (b, lower panel). 2DG-uptake was measured in cells after stimulation with INS or EXE (c). Data are represented as fold increase over control ± SD of three independent experiments (*p < 0.001, **p < 0.01 vs basal). 2DG-uptake was also measured in cells transfected with the AMPK siRNA 2 or control SiNR, before and after stimulation with EXE. Data are shown as fold increase over control ± SD of three independent experiments (d) (**p < 0.01 vs basal)
Fig. 6 EXE induces 2DG-uptake via AMPKα activation in L6 myotubes. L6 myotubes were transfected with specific AMPK siRNAs. After transfection, the cells were stimulated with 100 nmol/l EXE or 100 nmol/l INS. Proteins were then extracted and probed with AMPKα (a) and phospho-specific AMPKα T172 (b) antibodies. To normalize the blots for protein levels, the blots were stripped and re-probed with anti-tubulin (a, lower panel) and AMPKα antibodies (b, lower panel). 2DG-uptake was measured in cells after stimulation with INS or EXE (c). Data are represented as fold increase over control ± SD of three independent experiments (*p < 0.001, **p < 0.01 vs basal). 2DG-uptake was also measured in cells transfected with the AMPK siRNA 2 or control SiNR, before and after stimulation with EXE. Data are shown as fold increase over control ± SD of three independent experiments (d) (**p < 0.01 vs basal)CC BY · PubMed Central
Fig. 7 Effects of EXE and Lira on AMPK and AKT phosphorylation in differentiated L6 cells. After 20 min- and 48 h incubation with EXE and Lira, both at 100 nmol/l, levels of Thr172 (a) and Ser 473 (b) phosphorylation were measured. 2DG-uptake (c) was measured in L6 myotubes treated for 30 min with 100 nmol/l INS and 100 nmol/l EXE and Lira for 20 min and 48 h. Each bar represents the mean ± SD of three independent experiments as shown. (*p < 0.01 and **p < 0.02 vs. control)
Fig. 7 Effects of EXE and Lira on AMPK and AKT phosphorylation in differentiated L6 cells. After 20 min- and 48 h incubation with EXE and Lira, both at 100 nmol/l, levels of Thr172 (a) and Ser 473 (b) phosphorylation were measured. 2DG-uptake (c) was measured in L6 myotubes treated for 30 min with 100 nmol/l INS and 100 nmol/l EXE and Lira for 20 min and 48 h. Each bar represents the mean ± SD of three independent experiments as shown. (*p < 0.01 and **p < 0.02 vs. control)CC BY · PubMed Central
Fig. 8 Effects of EXE on MGO-induced insulin resistance in L6 myotubes. 2DG-uptake in cultured L6 myotubes pre-incubated with 2.5 mmol/l MGO and stimulated with INS and EXE both at 100 nmol/l. Data are shown as mean ± SD of three independent experiments (*p < 0.01 vs basal and MGO)
Fig. 8 Effects of EXE on MGO-induced insulin resistance in L6 myotubes. 2DG-uptake in cultured L6 myotubes pre-incubated with 2.5 mmol/l MGO and stimulated with INS and EXE both at 100 nmol/l. Data are shown as mean ± SD of three independent experiments (*p < 0.01 vs basal and MGO)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 56 references

Cited by

See all 102

Metadata

Authors
Andreozzi, F., Raciti, G. A., Nigro, C., Mannino, G. C., Procopio, T., Davalli, A. M., Beguinot, F., Sesti, G., Miele, C., & Folli, F.
Affiliations
  • The University of Texas at San Antonio Health Science Center (US)
  • Institute for Experimental Endocrinology and Oncology (IT)
  • Magna Graecia University (IT)
  • IRCCS Ospedale San Raffaele (IT)
Corresponding author
  • Andreozzi, Francesco
  • Folli, Franco
Venue
Journal of Translational Medicine
Published
2016-07-30
Volume
14
Issue
1
Pages
229-229
ISSN
1479-5876 (ISSN-L)
OpenAlex
W2496216273
Cited by
102
References
56
Citations by year
2026: 3 · 2025: 24 · 2024: 20 · 2023: 10 · 2022: 8 · 2021: 7 · 2020: 6 · 2019: 11 · 2018: 9 · 2017: 4
FWCI
4.16
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Journal of Translational Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
  • Americanae (AECID Library) (submittedVersion, other-oa)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
Funders
  • Ministero dell’Istruzione, dell’Università e della Ricerca (FIRB-MERIT)
  • Società Italiana di Diabetologia (Scholarship by FO.DI.RI. and MSD 2014)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
Keywords
exenatide, liraglutide, GLP-1 receptor agonists, AMPK, glucose uptake, skeletal muscle, insulin-independent glucose transport, GLUT4 translocation, insulin resistance, methylglyoxal, insulin signaling, L6 myotubes
MeSH terms
Glucagon-Like Peptide-1 Receptor, Liraglutide, Exenatide, Glucagon-Like Peptide-1 Receptor Agonists, Animals, Biological Transport, Cell Line, Deoxyglucose, Enzyme Activation, Glucose, Humans, Insulin Resistance, Papio, Peptides, Phosphorylation, Pyruvaldehyde, Time Factors, Venoms, Signal Transduction, Muscle Fibers, Skeletal, Gene Silencing, Gene Expression Profiling, Proto-Oncogene Proteins c-akt, Mice, Rats, AMP-Activated Protein Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The GLP-1 receptor agonists exenatide and liraglutide activate Glucose transport by an AMPK-dependent mechanism. https://app.cochat.ai/papers/10.1186/s12967-016-0985-7
The paper
Andreozzi, F., Raciti, G. A., Nigro, C., Mannino, G. C., Procopio, T., Davalli, A. M., Beguinot, F., Sesti, G., Miele, C., & Folli, F. (2016). The GLP-1 receptor agonists exenatide and liraglutide activate Glucose transport by an AMPK-dependent mechanism. Journal of Translational Medicine. https://doi.org/10.1186/s12967-016-0985-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.